![Philippe Halfon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Halfon active positions
Companies | Position | Start | End |
---|---|---|---|
Genoscience Pharma
![]() Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Director/Board Member | 2000-12-31 | - |
Founder | 2000-12-31 | - | |
President | 2000-12-31 | - |
Career history of Philippe Halfon
Statistics
International
France | 2 |
Operational
Director/Board Member | 1 |
Founder | 1 |
President | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Genoscience Pharma
![]() Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Health Technology |
- Stock Market
- Insiders
- Philippe Halfon
- Experience